Author Page for Vikram Paradkar

Selection of Optimum Formulation of RBD-Based Protein Sub-Unit Covid19 Vaccine (Corbevax) Based on Safety and Immunogenicity in an Open-Label, Randomized Phase-1 and 2 Clinical Studies

Number of pages: 48 Posted: 09 Mar 2022

Subhash Thuluva, Vikram Paradkar, Kishore Thuraga, Subbareddy Gunneri, Vijay Yerroju, Rammohanreddy Mogulla, Mahesh Kyasani, Senthilkumar Manoharan, Guruprasad Medigeshi, Janmejay Singh, Heena Shaman, Chandramani Singh and Venkateshwar Rao A

Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Government of India - Translational Health Science & Technology Institute (THSTI), Government of India - Vaccine and Infectious Disease Research Center, Government of India - Vaccine and Infectious Disease Research Center, All India Institute of Medical Sciences (AIIMS), Bhopal and St. Theresa s Hospital - Department of General Medicine

Downloads 93 (732,131)

Abstract:

Selection of Optimum Formulation of RBD-Based Protein Sub-Unit COVID19 Vaccine (Corbevax) Based on Safety and Immunogenicity in an Open-Label, Randomized Phase-1 and 2 Clinical Studies

Number of pages: 50 Posted: 11 Mar 2022

Subhash Thuluva, Vikram Paradkar, Kishore Thuraga, Subbareddy Gunneri, Vijay Yerroju, Rammohanreddy Mogulla, Mahesh Kyasani, Senthilkumar Manoharan, Guruprasad Medigeshi, Janmejay Singh, Heena Shaman, CM Singh and Venkateshwar Rao A

Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Government of India - Translational Health Science & Technology Institute (THSTI), Government of India - Vaccine and Infectious Disease Research Center, Government of India - Vaccine and Infectious Disease Research Center, All India Institute of Medical Sciences (AIIMS) - Department of Community and Family Medicine and St. Theresa s Hospital - Department of General Medicine

Downloads 76 (840,816)

Vikram Paradkar

Biological E Limited

1

169

0

Scholarly Papers (1)

Selection of Optimum Formulation of RBD-Based Protein Sub-Unit Covid19 Vaccine (Corbevax) Based on Safety and Immunogenicity in an Open-Label, Randomized Phase-1 and 2 Clinical Studies

Selection of Optimum Formulation of RBD-Based Protein Sub-Unit Covid19 Vaccine (Corbevax) Based on Safety and Immunogenicity in an Open-Label, Randomized Phase-1 and 2 Clinical Studies

Abstract:

Selection of Optimum Formulation of RBD-Based Protein Sub-Unit COVID19 Vaccine (Corbevax) Based on Safety and Immunogenicity in an Open-Label, Randomized Phase-1 and 2 Clinical Studies

Abstract: